| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686341 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009800A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009613A1 Anti-inflammatory or anti-allergic androstane complexes |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009580A1 Novel compounds |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009573A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009557A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009542A2 Process for preparing certain pyrrolotriazine compounds |
| 01/29/2004 | WO2004009536A1 Novel compounds as histone deacetylase inhibitors |
| 01/29/2004 | WO2004009528A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | WO2004009120A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/29/2004 | WO2004009103A1 Probiotics for gut neuromuscular functions |
| 01/29/2004 | WO2004009072A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | WO2004009064A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 01/29/2004 | WO2004009063A1 TOPICAL ANTIINFLAMMATORY PREPARATIONS OF η-TERPINENE |
| 01/29/2004 | WO2004009061A2 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 01/29/2004 | WO2004009056A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 01/29/2004 | WO2004009030A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003041650A3 Modulation of lir function to treat rheumatoid arthritis |
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | WO2003009803A3 Method of improving cognitive function |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002038106A3 Calcilytic compounds |
| 01/29/2004 | US20040019210 Kinase inhibitors |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019207 Amines such as 8-Benzyl-3-(3-pyridyl)-8-azabicyclo(3.2.1) oct-2-ene, that bind to nicotinic acetocholine receptors, used for prophylaxis of nervous system disorders, as analgesis, antiinflammatory agents and drug abuse |
| 01/29/2004 | US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 01/29/2004 | US20040019122 Solid dispersion composition |
| 01/29/2004 | US20040019111 A new use of existing pharmaceutical, a nonsteroidal antiinflammatory agents |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019094 N-imine guanidine compounds; treatment of obesity, anorexia, inflammation and mental disorders |
| 01/29/2004 | US20040019084 Nitric oxide synthase inhibitors; antioxidant regenerants |
| 01/29/2004 | US20040019077 Heterocyclic imines such as N1-(8-sulfonamide-5-isoquinoline)-N2-(3,3-diphenyl-2-propenyl) -ethylenediamine, used for prophylaxis and diagnosis of cancers, diabetes, cardiovascular and nervous system disorders, autoimmune diseases or obesity |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019070 Nitrogen compounds used as opiate receptor agonists or antagonists, for prophylaxis of drug abuse, cardiovascular, respiratory system, gastrointestinal disorders, as analgesics, antitussives or immunosuppressants |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | US20040019055 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019011 Treatment of conitions and disease |
| 01/29/2004 | US20040019001 Modulation gene expression |
| 01/29/2004 | US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents |
| 01/29/2004 | US20040018991 Topical treatment for mastalgia |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018956 Aporphine esters and their use in therapy |
| 01/29/2004 | US20040018605 Anticancer agents; autoimmune diseases; central nervous system disorders; polymerase chain reactions |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018232 Drugs comprising titanium dioxide pigments, titanium dioxide and/or iron oxide coated on inorganic substrates; use as food color |
| 01/29/2004 | US20040018214 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018213 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018212 Treating a non-spasm caused pain with botulinum toxin |
| 01/29/2004 | US20040018190 Drugs and foods improving the quality of life and process for producing the same |
| 01/29/2004 | CA2493876A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | CA2493774A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | CA2493544A1 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/29/2004 | CA2493341A1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | CA2493255A1 Probiotics for gut neuromuscular functions |
| 01/29/2004 | CA2493234A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492911A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/29/2004 | CA2492861A1 Process for preparing certain pyrrolotriazine compounds |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2492651A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | CA2492110A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | CA2491131A1 Novel compounds as histone deacetylase inhibitors |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1384723A1 4-Hydroxy-2H-thieno[2,3-e]-1,2-thiazin-3-carboxamide-1,1-dioxides, process for their preparation and pharmaceutical compositions containing them |
| 01/28/2004 | EP1384485A1 Bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 01/28/2004 | EP1384483A1 Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| 01/28/2004 | EP1384477A1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 01/28/2004 | EP1384471A1 Osmotic extented-release dosage form |
| 01/28/2004 | EP1384081A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |